XML 17 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash flows from operating activities:    
Net income $ 6,030 $ 6,270
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 2,646 1,696
Stock-based compensation expense 2,672 1,629
Provision adjustments related to doubtful accounts 7 20
Provision adjustments related to product warranty 488 302
Impairments 468 0
Recognition of previously deferred gain on sale of assets from discontinued operations 0 (3,804)
Net gain on disposal of equipment (322) (41)
Other 321 (1,422)
Total non-cash adjustments 6,280 (1,620)
Changes in operating assets and liabilities:    
Accounts receivable (3,878) (4,358)
Inventory (1,782) (6,420)
Other assets (2,627) 120
Accounts payable 2,951 2,884
Accrued expenses and other current liabilities 834 (1,118)
Total change in operating assets and liabilities (4,502) (8,892)
Net cash provided by (used in) operating activities 7,808 (4,242)
Cash flows from investing activities:    
Purchase of equipment (7,262) (4,480)
Receipt of escrow funds from sale of assets 0 1,853
Proceeds from disposal of property, plant and equipment 339 50
Net cash used in investing activities (6,923) (2,577)
Cash flows from financing activities:    
Proceeds from stock plans 797 614
Net cash provided by financing activities 797 614
Effect of exchange rate changes on foreign currency (35) 210
Net increase (decrease) in cash, cash equivalents and restricted cash 1,647 (5,995)
Cash, cash equivalents and restricted cash at beginning of period 64,870 112,260
Cash, cash equivalents and restricted cash at end of period 66,517 106,265
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the period for interest 55 65
Cash paid during the period for income taxes 79 123
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Changes in accounts payable related to purchases of equipment (549) (432)
Issuance of common stock to Board of Directors $ 410 $ 263